By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antineoplastics > Ciltacabtagene autoleucel
Miscellaneous antineoplastics

Ciltacabtagene autoleucel

https://themeditary.com/drug/ciltacabtagene-autoleucel-7930.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 16, 2023  Additional Content by TheMediTary.Com

Generic name: ciltacabtagene autoleucel [ sil-ta-kab-ta-jeen-aw-toe-loo-sel ]

Drug class: Miscellaneous antineoplastics

Dosage form: intravenous suspension (-)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Carvykti

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Ciltacabtagene autoleucel?

Ciltacabtagene autoleucel is an immunotherapy medicine used to treat multiple myeloma in adults. ciltacabtagene autoleucel is given after at least four other treatments have failed.

Ciltacabtagene autoleucel is available under a special program. You must be registered in the program and understand the risks and benefits of this medicine.

Ciltacabtagene autoleucel may also be used for purposes not listed in this medication guide.

Warnings

A serious side effect of ciltacabtagene autoleucel is called cytokine release syndrome, which causes fever, chills, trouble breathing, vomiting, and other symptoms. Your caregivers will have medication available to quickly treat this condition if it occurs.

How should I take Ciltacabtagene autoleucel

Ciltacabtagene autoleucel is available only at an authorized hospital or clinic, and must be given by specially trained healthcare professionals.

Ciltacabtagene autoleucel is given after a procedure called leukapheresis (LOO-kuh-fuh-REE-sis).

During leukapheresis, some of your blood is collected through a small tube (catheter) placed into a vein. The catheter is connected to a machine that separates your white blood cells from other parts of the blood. The cells are then sent to a laboratory where they are made into ciltacabtagene autoleucel, a process that will take 4 to 5 weeks.

About 3 days before ciltacabtagene autoleucel is given, you will be pre-treated with chemotherapy to help prepare your body for ciltacabtagene autoleucel.

Just before you receive ciltacabtagene autoleucel, you will be given other medications to help prevent serious side effects or allergic reaction.

Once your body is ready to receive ciltacabtagene autoleucel, your care providers will inject the medicine into a vein through an IV.

You will be watched closely after you receive ciltacabtagene autoleucel, to make sure you do not have an allergic reaction or serious side effects.

You will need frequent blood tests to be sure ciltacabtagene autoleucel has not caused harmful effects.

Using ciltacabtagene autoleucel may increase your risk of developing other cancers. Ask your doctor about this risk. You may need cancer screening tests for the rest of your life.

Ciltacabtagene autoleucel may cause false results on a laboratory test for human immunodeficiency virus (HIV). Tell any doctor who treats you that you are using ciltacabtagene autoleucel.

For at least 4 weeks, plan to stay near the hospital or clinic where you received ciltacabtagene autoleucel. Avoid being so far away that it takes you longer than 2 hours to travel back to the hospital.

Dosing information

Usual Adult Dose for Multiple Myeloma:

Provided as one bag with a single dose for IV infusion:
Recommended dose range: 0.5 to 1.0 × 10(6) CAR-positive viable T cells per kg of body weight
Maximum dose of 1×10(8) CAR-positive viable T cells per single infusion
Treatment duration: The single IV infusion should be administered within 2.5 hours

Comments:
-This drug is for autologous use only. The patient identity must match the identifiers on the drug cassette and infusion bag. Do not use if the information on the patient-specific labels does not match.

Use: For the treatment of adult patients with relapsed or refractory multiple myeloma, after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD 38 monoclonal antibody.

Detailed Ciltacabtagene autoleucel dosage information
Ciltacabtagene autoleucel Dosage information (more detail)

Before Taking

Tell your doctor if you have ever had:

  • neurologic problems (such as stroke, seizures, memory loss);

  • breathing problems;

  • heart problems;

  • liver or kidney disease;

  • recent or active infection; or

  • low blood counts.

Women will need pregnancy testing before receiving this medicine. You also will need to use birth control to prevent pregnancy during treatment with ciltacabtagene autoleucel. Tell your doctor if you are pregnant or plan to become pregnant.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

What happens if I miss a dose?

Call your doctor for instructions if you miss any of your chemotherapy treatment, or if you miss a dose of your medications to prevent side effects of ciltacabtagene autoleucel.

What happens if I overdose?

In a medical setting an overdose would be treated quickly.

What should I avoid while using Ciltacabtagene autoleucel?

ciltacabtagene autoleucel can cause weakness, drowsiness, confusion, problems with memory or coordination, and seizures. Avoid driving or operating machinery for at least 8 weeks after you are treated with ciltacabtagene autoleucel.

Ask your doctor before you receive a "live" vaccine. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.

Do not donate blood, an organ, or any tissues or cells.

Ciltacabtagene autoleucel side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

A serious side effect of ciltacabtagene autoleucel is called cytokine release syndrome (CRS). Tell your caregivers right away if you have signs of this condition: fever, chills, trouble breathing, severe vomiting or diarrhea, tremors, shaking, fast or irregular heartbeats, feeling light-headed, or feeling very tired. Your caregivers will have medication available to quickly treat CRS if it occurs.

Also call your doctor at once if you have:

  • confusion, loss of consciousness, seizures, problems with speech, reading or writing, depression;

  • tingling and numbness of hands and feet , leg and arm weakness, facial numbness; or

  • low blood cell counts--fever, chills, tiredness, flu-like symptoms, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.

Common side effects of ciltacabtagene autoleucel may include:

  • confusion, cough, trouble breathing, fast or irregular heartbeats, feeling light-headed or very tired;

  • headache, dizziness;

  • problems with speech;

  • low blood cell counts;

  • fever, chills, tiredness, or other signs of infection;

  • decreased appetite, constipation, nausea or diarrhea; or

  • pain in your joints or muscles.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Ciltacabtagene autoleucel Side Effects

What other drugs will affect Ciltacabtagene autoleucel?

Other drugs may affect ciltacabtagene autoleucel, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

More about Ciltacabtagene autoleucel (Ciltacabtagene autoleucel [ sil-ta-kab-ta-jeen-aw-toe-loo-sel ])

Dosage information
Ciltacabtagene autoleucel Side Effects
During pregnancy
Drug images
Side effects
Drug class: Miscellaneous antineoplastics

Related treatment guides

Multiple Myeloma
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by